<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01043965</url>
  </required_header>
  <id_info>
    <org_study_id>0925</org_study_id>
    <secondary_id>nata925</secondary_id>
    <nct_id>NCT01043965</nct_id>
  </id_info>
  <brief_title>Myocardial Perfusion in Type 2 Diabetes</brief_title>
  <official_title>Evaluation of Myocardial Perfusion and Microvascular Reserve in Real-time Utilizing Myocardial Contrast Echocardiography in Type 2 Diabetes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aimed to evaluate microvascular circulation with novel method: real-time
      myocardial contrast echocardiography in patients with type 2 diabetes and normal coronary
      arteries.

      Myocardial blood flow reserve will be determined by quantitative contrast Stress
      echocardiography. Diabetic individuals will be evaluate in a decompensated state (Phase 1)
      and after optimization of medical treatment four months later (Phase 2).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early stages of epicardial atherosclerosis in patients with type 2 diabetes are associated
      with an impairment in endothelium-dependent dilation of the coronary microvasculature,
      indicating that the pathophysiological consequences of atherosclerosis may extend into the
      coronary microcirculation.

      The investigators will evaluate three parameters of myocardial quantification with contrast
      Stress echocardiography and correlate with HbA1C levels.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>myocardial blood flow velocity, myocardial blood flow reserve</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Diabetes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Type 2 diabetes patients without obstructive coronary disease. Interventional group: lifestyle changes and treatment with metformin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group - normal, healthy individuals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin</intervention_name>
    <description>Metformin 850mg</description>
    <arm_group_label>Diabetes</arm_group_label>
    <other_name>Glucophage</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes mellitus

          -  Normal echocardiogram

          -  Absence of obstructive epicardial coronary disease

        Exclusion Criteria:

          -  Obstructive coronary disease

          -  Heart valve disease

          -  COPD

          -  Cardiac Arrhythmias

          -  Cardiomyopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wilson Mathias Jr, Md, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Heart Institute - Sao Paulo - Brazil</affiliation>
  </overall_official>
  <verification_date>August 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2010</study_first_submitted>
  <study_first_submitted_qc>January 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2010</study_first_posted>
  <last_update_submitted>January 6, 2010</last_update_submitted>
  <last_update_submitted_qc>January 6, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2010</last_update_posted>
  <responsible_party>
    <name_title>Wilson Mathias Jr</name_title>
    <organization>Heart Institute - Sao Paulo - Brazil</organization>
  </responsible_party>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Myocardial perfusion imaging</keyword>
  <keyword>Heart diseases</keyword>
  <keyword>Echocardiography</keyword>
  <keyword>Endothelium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

